382 related articles for article (PubMed ID: 27892653)
41. Predicting NK cell subsets using gene expression levels in peripheral blood and endometrial biopsy specimens.
Davies ML; Dambaeva SV; Katukurundage D; Repak M; Gilman-Sachs A; Kwak-Kim J; Beaman KD
Am J Reprod Immunol; 2017 Sep; 78(3):. PubMed ID: 28771871
[TBL] [Abstract][Full Text] [Related]
42. Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab.
Martens A; Wistuba-Hamprecht K; Geukes Foppen M; Yuan J; Postow MA; Wong P; Romano E; Khammari A; Dreno B; Capone M; Ascierto PA; Di Giacomo AM; Maio M; Schilling B; Sucker A; Schadendorf D; Hassel JC; Eigentler TK; Martus P; Wolchok JD; Blank C; Pawelec G; Garbe C; Weide B
Clin Cancer Res; 2016 Jun; 22(12):2908-18. PubMed ID: 26787752
[TBL] [Abstract][Full Text] [Related]
43. Immature and activated phenotype of blood NK cells is associated with acute rejection in adult liver transplant.
Song S; Zhi Y; Tian G; Sun X; Chen Y; Qiu W; Jiao W; Huang H; Yu Y; Li M; Lv G
Liver Transpl; 2023 Aug; 29(8):836-848. PubMed ID: 37002601
[TBL] [Abstract][Full Text] [Related]
44. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells.
Juelke K; Killig M; Luetke-Eversloh M; Parente E; Gruen J; Morandi B; Ferlazzo G; Thiel A; Schmitt-Knosalla I; Romagnani C
Blood; 2010 Aug; 116(8):1299-307. PubMed ID: 20505160
[TBL] [Abstract][Full Text] [Related]
45. Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer.
Koo KC; Shim DH; Yang CM; Lee SB; Kim SM; Shin TY; Kim KH; Yoon HG; Rha KH; Lee JM; Hong SJ
PLoS One; 2013; 8(11):e78049. PubMed ID: 24223759
[TBL] [Abstract][Full Text] [Related]
46. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver.
Harmon C; Robinson MW; Fahey R; Whelan S; Houlihan DD; Geoghegan J; O'Farrelly C
Eur J Immunol; 2016 Sep; 46(9):2111-20. PubMed ID: 27485474
[TBL] [Abstract][Full Text] [Related]
47. Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells.
Keating SE; Zaiatz-Bittencourt V; Loftus RM; Keane C; Brennan K; Finlay DK; Gardiner CM
J Immunol; 2016 Mar; 196(6):2552-60. PubMed ID: 26873994
[TBL] [Abstract][Full Text] [Related]
48. Altered Expression of Natural Cytotoxicity Receptors and NKG2D on Peripheral Blood NK Cell Subsets in Breast Cancer Patients.
Nieto-Velázquez NG; Torres-Ramos YD; Muñoz-Sánchez JL; Espinosa-Godoy L; Gómez-Cortés S; Moreno J; Moreno-Eutimio MA
Transl Oncol; 2016 Oct; 9(5):384-391. PubMed ID: 27641642
[TBL] [Abstract][Full Text] [Related]
49. Circulating CD56
de Jonge K; Ebering A; Nassiri S; Maby-El Hajjami H; Ouertatani-Sakouhi H; Baumgaertner P; Speiser DE
Sci Rep; 2019 Mar; 9(1):4487. PubMed ID: 30872676
[TBL] [Abstract][Full Text] [Related]
50. CD56
Chen T; Liu C; Li L; Liu H; Wang T; Shao Z; Fu R
Int J Lab Hematol; 2019 Jun; 41(3):353-363. PubMed ID: 30779419
[TBL] [Abstract][Full Text] [Related]
51. Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1.
Haag GM; Zoernig I; Hassel JC; Halama N; Dick J; Lang N; Podola L; Funk J; Ziegelmeier C; Juenger S; Bucur M; Umansky L; Falk CS; Freitag A; Karapanagiotou-Schenkel I; Beckhove P; Enk A; Jaeger D
Eur J Cancer; 2018 Feb; 90():122-129. PubMed ID: 29306769
[TBL] [Abstract][Full Text] [Related]
52. Specific phenotype and function of CD56-expressing innate immune cell subsets in human thymus.
Gerstner S; Köhler W; Heidkamp G; Purbojo A; Uchida S; Ekici AB; Heger L; Luetke-Eversloh M; Schubert R; Bader P; Klingebiel T; Koehl U; Mackensen A; Romagnani C; Cesnjevar R; Dudziak D; Ullrich E
J Leukoc Biol; 2016 Dec; 100(6):1297-1310. PubMed ID: 27354408
[TBL] [Abstract][Full Text] [Related]
53. Third-line pembrolizumab-induced immune-related interstitial pneumonitis after ipilimumab and nivolumab failure.
Oya K; Nakamura Y; Fujisawa Y; Endo R; Tanaka R; Ishitsuka Y; Maruyama H; Watanabe R; Okiyama N; Fujimoto M
Eur J Dermatol; 2018 Feb; 28(1):129-130. PubMed ID: 29400284
[No Abstract] [Full Text] [Related]
54. Hormonal stimulation for IVF treatment positively affects the CD56bright/CD56dim NK cell ratio of the endometrium during the window of implantation.
Lukassen HG; Joosten I; van Cranenbroek B; van Lierop MJ; Bulten J; Braat DD; van der Meer A
Mol Hum Reprod; 2004 Jul; 10(7):513-20. PubMed ID: 15155817
[TBL] [Abstract][Full Text] [Related]
55. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
Chang YJ; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2008 Mar; 14(3):323-34. PubMed ID: 18275899
[TBL] [Abstract][Full Text] [Related]
56. Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients.
Ali TH; Pisanti S; Ciaglia E; Mortarini R; Anichini A; Garofalo C; Tallerico R; Santinami M; Gulletta E; Ietto C; Galgani M; Matarese G; Bifulco M; Ferrone S; Colucci F; Moretta A; Kärre K; Carbone E
Nat Commun; 2014 Dec; 5():5639. PubMed ID: 25472612
[TBL] [Abstract][Full Text] [Related]
57. Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study.
Urun Y; Yasar HA; Turna H; Esin E; Sedef AM; Alkan A; Oksuzoglu B; Ozdemir N; Sendur MN; Sezer A; Kılıckap S; Utkan G; Akman T; Akbulut H; Celik I; Abalı H
J Oncol Pharm Pract; 2019 Oct; 25(7):1658-1664. PubMed ID: 30400750
[TBL] [Abstract][Full Text] [Related]
58. Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma.
Ladányi A; Papp E; Mohos A; Balatoni T; Liszkay G; Oláh J; Varga A; Lengyel Z; Emri G; Ferrone S
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554608
[TBL] [Abstract][Full Text] [Related]
59. Interferon-γ production by tubulointerstitial human CD56
Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
[TBL] [Abstract][Full Text] [Related]
60. Activation status of CD56
Liu M; Liu J; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2021 Mar; 40(3):1103-1112. PubMed ID: 32797360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
